All Stories

  1. The Hybrid Compounds as Multi-target Ligands for the Treatment of Alzheimer's Disease: Considerations on Donepezil

    Article • Current Topics in Medicinal Chemistry, February 2022, Bentham Science Publishers

    Hayrettin Ozan Gulcan

  2. Selected Natural and Synthetic Agents Effective against Parkinson’s Disease with Diverse Mechanisms

    Article • Current Topics in Medicinal Chemistry, January 2022, Bentham Science Publishers

    Hayrettin Ozan Gulcan

  3. Amendatory Effect of Flavonoids in Alzheimer's Disease Against Mitochondrial Dysfunction

    Article • Current Drug Targets, September 2021, Bentham Science Publishers

    Hayrettin Ozan Gulcan

  4. A Recent Look into Natural Products that have Potential to Inhibit Cholinesterases and Monoamine Oxidase B: Update for 2010-2019

    Article • Combinatorial Chemistry & High Throughput Screening, December 2020, Bentham Science Publishers

    Hayrettin Ozan Gulcan

  5. The Main Targets Involved in Neuroprotection for the Treatment of Alzheimer’s Disease and Parkinson Disease

    Article • Current Pharmaceutical Design, March 2020, Bentham Science Publishers

    Hayrettin Ozan Gulcan

  6. Design, Synthesis and Investigation of New Diphenyl Substituted Pyridazinone Derivatives as Both Cholinesterase and Aβ-Aggregation Inhibitors

    Article • Medicinal Chemistry, January 2019, Bentham Science Publishers

    Hayrettin Ozan Gulcan, Nihan Oruklu, Fatma Aksakal

  7. Design, Synthesis and Characterization of Novel Urolithin Derivatives as Cholinesterase Inhibitor Agents

    Article • Letters in Drug Design & Discovery, September 2018, Bentham Science Publishers

    Hayrettin Ozan Gulcan, maryam norouzbahari

  8. Synthesis of Novel Benzothiazole-Piperazine Derivatives and Their Biological Evaluation as Acetylcholinesterase Inhibitors and Cytotoxic Agents

    Article • Anti-Cancer Agents in Medicinal Chemistry, January 2018, Bentham Science Publishers

    Dr Rengul Cetin-Atalay, Mine Yarim, Hayrettin Ozan Gulcan

  9. Marginally Designed New Profen Analogues Have the Potential to Inhibit Cyclooxygenase Enzymes

    Article • Archiv der Pharmazie, January 2015, Wiley

    Hayrettin Ozan Gulcan